Advancing Neuro-Oncology Treatment: Dr. David Reardon | Dana-Farber Cancer Institute

Advancing Neuro-Oncology treatment: Dr. David Reardon | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Helping Patients with Brain Cancer: Dr. David Reardon

Dana-Farber Cancer Institute

Immunotherapy for Brain Cancer, with David Reardon

Cancer Research Institute

Neuro-Oncology Conversations: Research on Immunotherapy for Brain Tumors

Dana-Farber Cancer Institute

Brain Cancer and Immunotherapy with Dr. David Reardon

Cancer Research Institute

Dr. David Reardon on Treating Glioblastoma Patients With EGFRvIII-Mutations

Targeted Oncology

ASCO22: Glioblastoma research by David Reardon, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Dr. David Reardon on Targeting Brain Tumors and Monitoring Resistances

Targeted Oncology

David Reardon on Caring for Patients With Glioblastoma

Advice for Newly Diagnosed Patients With GBM

Dr. Reardon on the Need for a New Standard of Care in GBM

How Can I Best Take Care of Myself During Immunotherapy? Ask a Scientist

Cancer Research Institute

Learn the Basics of Immunotherapy from David Reardon, M.D.

Cancer Research Institute

Facebook Live: What's New in Neuro-Oncology?

Dana-Farber Cancer Institute

Breaking Down Misconceptions about Glioblastoma

What Can I Expect from a Vaccine Trial for Glioblastoma? Ask a Scientist

Cancer Research Institute

The Inadequacy of the Current Standard of Care for Glioblastoma

Targeted Oncology

Dr. David Reardon on Immunotherapy and Rindopepimut in the Glioblastoma Treatment Paradigm

Targeted Oncology

Live Webchat: What's New in Brain Cancer Treatment?

Dana-Farber Cancer Institute

Dr. Reardon Discusses the Mechanism of Action of Rindopepimut for Recurrent Glioblastoma

Targeted Oncology